Postdoctoral positions are available immediately in the Cardiovascular Research Laboratory at Huntington Medical Research Institutes (HMRI), Pasadena, CA to investigate new mechanisms and therapies in models of heart attack, heart failure, cardiogenic and hemorrhagic shock, and cardiac toxicology. New pharmacologic therapies that protect the mitochondria during ischemia/reperfusion, remote ischemic conditioning and therapeutic hypothermia are recent therapeutic areas of focus of the laboratory. In addition, the acute and chronic effects of the now popular electronic cigarette smoke or vaping on the cardiovascular system in normal young versus old hearts, as well as hearts with underlying heart disease will be carefully examined. Furthermore, the effect of pure nicotine on the heart will be studied.
Candidates with a background in cardiovascular and myocardial biology will be preferred. Experience in small animal (rats and mice) surgery is a prerequisite. The candidate must have at least one year experience with rat and/or mice surgery including anesthesia, intubation, mechanical respiration, cut downs, catheterization of arteries and veins. Experience with myocardial infarction (heart attack) models, heart failure models and models of shock (cardiac and/or hemorrhagic) is preferred. Candidates, with a recent PhD degree, and a good track record of publications, will be given priority. The initial appointment will be for two years with the possibility of extension. Salary will be commensurate with qualifications, laboratory experience, and institutional guidelines. Most of our previous candidates who have completed a 2-year experience in our laboratory have successfully written scientific papers, as well as presented at major cardiovascular meetings such as the American Heart Association meetings and others. Many have gone on to successful careers in academic medicine and/or industry. The postdoctoral experience will include didactic lectures on a variety of scientific subjects including how to carry out scientific studies, as well as a seminar in grant writing.
Robert Kloner, MD, PhD
Chief Science Officer and Scientific Director, Cardiovascular Research Program
Huntington Medical Research Institutes (HMRI)